{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:03:00Z","timestamp":1771016580467,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2470,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,10,2]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The most frequent cause of episodic heartburn is food and beverage ingestion. Nizatidine, an H<jats:sub>2<\/jats:sub>\u2010receptor antagonist, is currently approved for non\u2010prescription use in the prevention and relief of heartburn at a dose of 75\u2003mg up to twice a day.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Two identical studies were carried out to evaluate the efficacy of nizatidine, 75\u2003mg, compared with placebo in treating heartburn in an \u2018at\u2010home\u2019 setting. The studies were multicentre, multiple\u2010dose, placebo\u2010controlled, randomized, parallel group design. A total of 994 subjects were randomized to treatment. Adequate relief of heartburn was assessed at 15, 30 and 45\u2003min and 1, 2 and 3\u2003h following a treatment dose. A subject\u2019s responses with respect to time to relief and attainment of adequate relief were combined into a derived response profile, the sustained adequate relief score. Adverse experiences were noted throughout the study period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The individual and combined study results showed that nizatidine, 75\u2003mg, relieved heartburn faster and\/or more consistently than placebo. The mean sustained adequate relief score, calculated over a subject\u2019s first four episodes, was 2.43 in the nizatidine\u2010treated group compared with 2.14 in the placebo group (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). Nizatidine\u2010treated subjects attained sustained adequate relief in a significantly (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) larger percentage (75%) of their heartburn episodes than did subjects treated with placebo (66%). No serious adverse experiences were associated with nizatidine treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Nizatidine, 75\u2003mg, is a safe and effective treatment for episodic heartburn. The results showed that subjects taking nizatidine had heartburn relief that was achieved faster and\/or more reliably than did subjects taking placebo.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.01073.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:43:10Z","timestamp":1047354190000},"page":"1571-1577","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness and safety of nizatidine, 75 mg, for the relief of episodic heartburn"],"prefix":"10.1111","volume":"15","author":[{"given":"K.","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Redman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1074","article-title":"Specific histamine (H2\u2010receptor) antagonist actions of nizatidine","volume":"43","author":"Evans DC","year":"1984","journal-title":"Fed Proc"},{"key":"e_1_2_6_3_2","first-page":"400","article-title":"Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions","volume":"239","author":"Lin TM","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_4_2","first-page":"1478","article-title":"A double\u2010blind controlled study proves nizatidine to be much more potent than cimetidine (Abstract)","volume":"88","author":"Linscheer WG","year":"1985","journal-title":"Gastroenterology"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1988.tb03103.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01071906"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","unstructured":"RobinsonMD.Gastroesophageal reflux disease\u2014selecting optimal therapy.Postgrad Med1994;92(2):88\u201394 99\u2013102.","DOI":"10.1080\/00325481.1994.11945795"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01536707"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.1.118"},{"key":"e_1_2_6_10_2","unstructured":"Product Information Axid.Physicans\u2019 Desk Reference 52nd edn. Montvale NJ: Medical Economics 1998: 1439."},{"key":"e_1_2_6_11_2","first-page":"A\u2010154790","article-title":"Nizatidine reduces meal induced gastroesophageal reflux (GER): a randomized, placebo controlled, double\u2010blinded, 4\u2010way crossover study","volume":"108","author":"Lynn RB","year":"1995","journal-title":"Gastroenterology"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1001\/archinte.1997.00440350102011","article-title":"A double\u2010blind, placebo\u2010controlled study of the effectiveness and safety of nizatidine in the prevention of postprandial heartburn","volume":"157","author":"Spiegel JE","year":"1997","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_13_2","unstructured":"Gastroesophageal reflux disease(hiatal hernia and heartburn).National Institutes of Health Publication no. 94\u2010882. Bethesda MD: National Institute of Diabetes and Digestive and Kidney Diseases 1994."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00384.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199505000-00003"},{"key":"e_1_2_6_16_2","first-page":"861","article-title":"Side\u2010effect profile of nonprescription nizatidine in the prevention of meal\u2010related heartburn","volume":"37","author":"Furey SA","year":"1997","journal-title":"J Clin Pharmacol"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01073.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01073.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.01073.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:04:41Z","timestamp":1697537081000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.01073.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,2]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2001,10,2]]}},"alternative-id":["10.1046\/j.1365-2036.2001.01073.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.01073.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10,2]]}}}